Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A 24-Week Randomized, Double-blind, Double-Dummy, Multicenter Study to Compare the Efficacy of AVANDIA when added to Submaximal Doses of Metformin and to Compare the Tolerability of the Combination to Metformin Monotherapy when Administered to Subjects with Type 2 Diabetes Mellitus
rosiglitazone
49653/284
NCT00501020
Diabetes Mellitus, Type 2
Phase 4
 
An analysis-ready dataset is not available for this study.
February 2015

Powered by ideaPoint, Inc.